|Bid||31.82 x 1300|
|Ask||32.85 x 3200|
|Day's Range||31.94 - 33.15|
|52 Week Range||17.56 - 44.46|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||19.43|
|Earnings Date||Nov 07, 2022 - Nov 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||41.33|
Subscribe to Yahoo Finance Plus to view Fair Value for AMPH
Top-ranked biotech stock Amphastar crashed Tuesday after the company received its second Food and Drug Administration rejection since June.
Image source: The Motley Fool. Amphastar Pharmaceuticals (NASDAQ: AMPH)Q2 2022 Earnings CallAug 08, 2022, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGreetings, and welcome to the Amphastar Pharmaceuticals second-quarter earnings call.
Amphastar (AMPH) delivered earnings and revenue surprises of 5.41% and 4.49%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?